
RxSight, Inc.
RXSTNASDAQHealthcareMedical - Devices
Previous close
$6.25
+$0.16 · +2.63%
RXST company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
57
Fair Value
Momentum
22
Weakening
Sentiment
69
Bullish
Risk resilience
30
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAs a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Aziz Mottiwala
- Listed since
- Jul 30, 2021
- Employees
- 461
Market position
Day range
Current $6.25
52-week range
Current $6.25
- Open
- $6.10
- Previous close
- $6.09
- Volume
- 1.54M
- 1.52× average
- Average volume
- 1.02M
- Average daily volume
- Market cap
- 258.73M USD
- Beta
- 1.13
- Market reference 1
- 50-day average
- $5.6346
- +10.92% above average
- 200-day average
- $7.6942
- -18.77% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -5.53×
- P/B (TTM)
- 0.98×
- P/S (TTM)
- 2.03×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 77.50%
- Operating margin
- -43.20%
- Net margin
- -36.80%
Financial health
- Debt / equity
- 0.04×
Earnings
- EPS beat rate
- 82%
- 9 beats, 2 misses, 0 met estimates
- Average EPS surprise
- +14.34%
- 11 comparable reports
- Latest EPS result
- -0.29
- Estimate -0.33 · Beat by 11.95%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
RXST peers
ETFs holding RXST
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI7.38M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM6.17M0.01%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF2.46M0.00%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN2.19M0.01%14.66B USD0.24%$224.81+0.45%
Vanguard Russell 2000 ETFVTWO1.34M0.01%17.4B USD0.06%$121.25+0.74%
Schwab U.S. Small-Cap ETFSCHA1.08M0.00%23.1B USD0.03%$34.83+0.52%
iShares Micro-Cap ETFIWC839.56K0.06%1.53B USD0.60%$198.39+1.10%
Vanguard Health Care ETFVHT714.88K0.00%20.9B USD0.09%$327.7+1.24%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 7.38M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 6.17M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 2.46M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 2.19M
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.34M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 1.08M
- Weight
- 0.00%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
iShares Micro-Cap ETFIWC- Market value
- 839.56K
- Weight
- 0.06%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Vanguard Health Care ETFVHT- Market value
- 714.88K
- Weight
- 0.00%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7+1.24%
Continue in GoAI
Research RXSTresearch.disclaimer





